IFP Advisors’s 10x Genomics TXG Stock Holding History
Bought
Maintained
Sold
Other funds holding TXG
AIM
QCM
NAMA
IFP Advisors's TXG Position: Q2 2026 in Review
IFP Advisors held its 10x Genomics (TXG) position steady in Q2 2026 at 1,250 shares worth $47.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2430.
IFP Advisors first reported a position in TXG in Q4 2019 and has held it in 23 quarters since. 390 funds tracked by Wall St. Rank hold TXG as of Q2 2026.
- IFP Advisors held 1,250 shares of 10x Genomics worth $47.9K as of Q2 2026.
- IFP Advisors left its 10x Genomics share count unchanged in Q2 2026.
- 10x Genomics made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #2430 holding.
- IFP Advisors first reported a position in 10x Genomics in Q4 2019 and has held it in 23 quarters since.
- 390 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2026.
Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.